Pages that link to "Q35052754"

The following pages link to Increased expression of cystine/glutamate antiporter in multiple sclerosis (Q35052754):

Displaying 42 items.

• Redox control of microglial function: molecular mechanisms and functional significance (Q27000279) (← links)
• Biomarkers in Multiple Sclerosis: An Up-to-Date Overview (Q27496017) (← links)
• High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells (Q28547125) (← links)
• Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial (Q30524879) (← links)
• European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). (Q33761211) (← links)
• Pathogenic implications of iron accumulation in multiple sclerosis (Q34049616) (← links)
• The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. (Q34279067) (← links)
• Change of cystine/glutamate antiporter expression in ethanol-dependent rats (Q34292046) (← links)
• Redox-based therapeutics in neurodegenerative disease (Q34535918) (← links)
• Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis (Q34807095) (← links)
• Thiol redox homeostasis in neurodegenerative disease (Q35614227) (← links)
• Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination (Q35815842) (← links)
• Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system (Q35838808) (← links)
• Roles of white matter in central nervous system pathophysiologies (Q35846494) (← links)
• Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis (Q36283207) (← links)
• Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis (Q36610373) (← links)
• Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats (Q36644482) (← links)
• PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats (Q37202278) (← links)
• Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis (Q37586538) (← links)
• Oxidative stress and cancer pain. (Q38078000) (← links)
• Classical and unconventional pathways of vesicular release in microglia (Q38102655) (← links)
• Neurotransmitter signaling in the pathophysiology of microglia (Q38102686) (← links)
• The role of glutamate and its receptors in multiple sclerosis (Q38196367) (← links)
• Neurotransmitter signaling in white matter (Q38206164) (← links)
• Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission (Q38580123) (← links)
• Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders (Q38618048) (← links)
• Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities (Q38939753) (← links)
• Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed (Q40400682) (← links)
• Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs (Q41682361) (← links)
• Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages. (Q42041432) (← links)
• Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage (Q42592261) (← links)
• P2X4 receptors control the fate and survival of activated microglia. (Q46356718) (← links)
• Cystine/glutamate antiporter blockage induces myelin degeneration. (Q48703799) (← links)
• In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis (Q49160094) (← links)
• [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis. (Q55174845) (← links)
• Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade (Q57110813) (← links)
• Clonal Glial Response in a Multiple Sclerosis Mouse Model (Q58572084) (← links)
• Transcriptomic Impact of IMA-08401, a Novel AHR Agonist Resembling Laquinimod, on Rat Liver (Q64076220) (← links)
• Mechanisms of neurobehavioral abnormalities in multiple sclerosis: Contributions from neural and immune components (Q64118459) (← links)
• Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation (Q92622351) (← links)
• Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome (Q96128246) (← links)
• Functionally Diverse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol-Associated Hepatitis (Q100467645) (← links)